Home › Graves Disease › New York
Graves Disease clinical trials in New York
5 studies for Graves Disease are looking for participants at sites in New York.
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
- Albany Medical College Community Endocrinology, Albany
- Endocrine Associates of West Village PC, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07570316Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Site 129, Niagara Falls
- Site 120, Orchard Park
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07682896A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1032, Long Island City
- Site Number - 1027, New Hyde Park
- Site Number - 1009, New York
- and 1 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT07018323A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1050, Monroe
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT06727604Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease
- Pediatric Endocrinology at Northwell Health, New Hyde Park
RecruitingPhase 2
Ages 9 to 17 · All sexes · Updated Jan 27, 2026 · NCT07369063From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.